58 2, 32 m2) и едновременно прилаганата CHOP терапия, е относително малка.
This variability in V1 (27.1% and 19.0%) contributed by the range in BSA (1.53 to 2.32 m2) and concurrent CHOP therapy, respectively, were relatively small.